Pfizer

After Pfizer proclaimed its vaccines had made it through Phase 3 with a 90 percent efficacy rate, travel directors experienced a cautious optimism. Consumer confidence is everything.

They have anticipated that this news will improve people’s confidence and mind-set about travel planning. It sets them and all the travel industry participants on a brighter path which will lead to recovery.

Subsequently after the beginning of the pandemic, everybody, experts especially, was waiting for a vaccine and believed that it would be an important element for the travel industry’s complete recovery. The latest news on the progress of a vaccine for COVID-19 is tremendously promising, and a major milestone for the industry, the economy, and people around the globe.

Reaching this critical revolutionary point in vaccine development at a time when the world needs it most with infection rates setting new records, hospitals nearing over-capacity, and economies struggling to reopen, is like a miracle. After months of dark and grey days, the sun is out again Pfizer claims.

 The travel industry is a vital driver of a nation’s jobs, economy, and quality of life. A potential vaccine holds promise for the world as a whole, and as a critical factor to finally increase consumer confidence in travel on a wider level.

The key to any vaccine will be an emotional investment on the part of the public to start traveling again, like to get on an airplane, to stay overnight in a hotel, to join other people at events like going to a concert or a movie theatre.

If 2020 has shown us anything, it’s the importance of connecting with others. Don’t you agree? We have missed our public activities long enough and let’s hope we shall never take it for granted ever again. A vaccine would bring us all one step closer to reconnecting, and once more feeling the joy of travel.